speaker
Conference Operator
Operator

Hello everyone. Thank you for joining us and welcome to Guardian Pharmacy's third quarter 2026 earnings call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star 1 on your telephone keypad. To withdraw your question, press star 1 again. I will now hand the call over to Ashley Stockton, Investor Relations. Please go ahead.

speaker
Ashley Stockton
Vice President, Investor Relations

Good afternoon. Thank you for participating in today's conference call. This is Ashley Stockton, Vice President, Investor Relations for Guardian Pharmacy Services. I'm joined on today's call by Fred Burke, President and Chief Executive Officer, David Morris, Chief Operating Officer, and Will Mudd, Chief Financial Officer. After market closed today, Guardian posted its financial results for the quarter ended September 30th, 2026. A copy of the press release is available on the company's investor relations website. Please note that today's discussion will include certain forward-looking statements that reflect our current assumptions and expectations, including those related to our future financial performance and industry and market conditions. Such forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from our expectations. We encourage you to review the information in today's press release and quarterly report on Form 10-Q, as well as the specific risk factors and uncertainties discussed in our annual report on Form 10-K. We do not undertake any duty to update any forward-looking statements which speak only as of the date they are made. On today's call, we will also use certain non-GAAP financial measures when discussing the company's financial performance and condition. You can find additional information on these non-GAAP measures and reconciliations to their most directly comparable GAAP financial measures in today's press release, which again is available on our Investor Relations website. And now I will turn it over to Fred for high-level commentary.

speaker
Fred Burke
President and Chief Executive Officer

Thank you, Ashley, and good afternoon, everyone. We're extremely pleased with our performance this year and the momentum we're seeing across the business. Our results reflect the strength of the Guardian model, The dedication of our teams and growing demand for high quality pharmacy services in the long term care setting. Given our performance year to date, we are raising our full year guidance, which Will will discuss in more detail. Before I hand it over to David on operations, I'd like to take a few minutes to discuss the broader economic environment, industry fundamentals, and how Guardian is positioned for continued growth. Looking across the broader economy, affordability, higher interest rates, and elevated operating costs all remain concerns. We believe the characteristics of the markets we serve and our business model help insulate Guardian from many of these issues. First, on affordability, it's well documented that those 75 and over are among the wealthiest segment of the population. We believe this provides an important foundation for long-term demand for private pay-assisted living, which represents approximately 70% of the residents we serve. Second, on interest rates, our debt-free balance sheet eliminates direct exposure to higher borrowing costs, while our cash generation has allowed us to fund our typical pace of market expansion without relying on external financing. Finally, our business is delivery intensive, making fuel an important operating expense, which unfortunately remains elevated. However, as we stated last quarter, our full year guidance already assumes these higher costs will persist through the remainder of the year. Beyond these macro considerations, Conditions across senior housing remain favorable and reinforce the value of Guardian's service model. Assisted living occupancy continues to improve, reaching 89% in the third quarter, according to NCMAP data, and is expected to continue to climb. At the same time, resident acuity remains elevated and labor challenges continue to pressure facility operators. As occupancy approaches historical highs and residents' care needs become more complex, operators increasingly need a sophisticated pharmacy partner like Guardian that can manage higher prescription volumes, support complex medication regimens, and invest in the capabilities needed to meet these evolving demands. Thank you for joining us. even if industry occupancy eventually reaches maximum capacity. At the heart of Guardian's strategy is our commitment to delivering exceptional high-touch pharmacy services to benefit the residents and facilities we serve. To sustain best-in-class service levels, It is imperative that we are appropriately compensated for the value our services provide in supporting better clinical outcomes and helping bend the cost curve in long-term care. Today, generics account for over 90% of our prescription volume and generate the vast majority of our gross profit. Accordingly, we are advancing a reimbursement model that better compensates us for the services we provide and places greater emphasis on our generic portfolio. This shift represents a meaningful evolution in our approach, one that we are helping to pioneer alongside our payor partners who increasingly recognize the need for greater transparency. Ultimately, we believe this approach will serve to de-risk our business model and enhance our longer-term stability. Taken together, Favorable industry fundamentals, substantial market share opportunity, and our differentiated service model should position Guardian exceptionally well for the future. Coupled with our efforts to strengthen reimbursement economics, consistent cash generation, and our highly liquid balance sheet, I am ever more confident in Guardian's ability to deliver durable growth and shareholder value. With that, I'll turn the call over to David.

Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-

Use this data in your own app

Pull this call's transcript, audio and slides with the Earnings call transcripts API.

See pricing

9,000+ companies · REST API

Investor presentation